help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 18, 2009
Endocrinology, doi:10.1210/en.2009-0206
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
150/9/4386    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Monahan, P.
Right arrow Articles by Raetzman, L. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monahan, P.
Right arrow Articles by Raetzman, L. T.

Submitted on February 17, 2009
Accepted on June 8, 2009

The Notch Target gene Hes1 regulates cell cycle inhibitor expression in the developing pituitary

Pamela Monahan, Sabina Rybak, and Lori T. Raetzman*

Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign

* To whom correspondence should be addressed. E-mail: raetzman{at}life.uiuc.edu.

The pituitary is an endocrine gland responsible for the release of hormones, which regulate growth, metabolism and reproduction. Diseases such as hypopituitarism or pituitary adenomas are able to disrupt pituitary function leading to suboptimal function of the entire endocrine system. Growth of the pituitary during development and adulthood is a tightly regulated process. HES1, a transcription factor whose expression is initiated by the Notch signaling pathway, is a repressor of cell cycle inhibitors. We hypothesize that with the loss of Hes1, pituitary progenitors are no longer maintained in a proliferative state choosing instead to exit the cell cycle. To test this hypothesis, we examined the expression of cell cycle regulators in wildtype and Hes1 deficient pituitaries. Our studies indicate that in early pituitary development (e10.5), cells contained in the Rathke's pouch (RP) of Hes1 mutants have decreased proliferation, indicated by changes in phosphohistone H3 expression. Furthermore, pituitaries lacking Hes1 have increased cell cycle exit, shown by significant increases in the cyclin dependent kinase inhibitors, p27 and p57, from e10.5-e14.5. Additionally, Hes1 mutant pituitaries have ectopic expression of p21 in RP progenitors, an area coincident with increased cell death. These observations taken together indicate a role for HES1 in the control of cell cycle exit and in mediating the balance between proliferation and differentiation, allowing for the properly timed emergence of hormone secreting cell types.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society